DGAP - News - Magyar Tőkepiac

Közzétételek - archívum

|

DGAP- Adhoc | DGAP - DD | DGAP - PVR | DGAP - NVR | DGAP - AFR | DGAP - CMS | DGAP - News

Sz	V	H	K	Sz	Cs	P	Sz	V	H	K	Sz	Cs	P	Sz	V	H	K	Sz	Cs	P	Sz	V	H	K	Sz	Cs	P	Sz	V
1	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17	18	19	20	21	22	23	24	25	26	27	28	29	30

DGAP - News (Vállalati hírek)

»	DGAP-News: Hapag-Lloyd AG: Hapag-Lloyd Annual General Meeting approves dividend of EUR 0.15 per share, Michael Behrendt re-elected to the Supervisory Board and confirmed as its Chairman [2019.06.12. 14:25]

»
DGAP-News: Hapag-Lloyd AG: CFO Nicolás Burr to take over new projects in Chile in 2020

[2019.06.12. 10:56]
»
DGAP-News: Hapag-Lloyd AG: Finanzvorstand Nicolás Burr übernimmt in 2020 neue Projekte in Chile

[2019.06.12. 10:56]
»
DGAP-News: Achiko Ltd.: Fintech Achiko Limited Plans for a Direct Listing on the SIX Exchange

[2019.06.12. 08:30]
»
DGAP-News: Achiko Ltd.: Fintech Achiko Limited plant Notierung an SIX Swiss Exchange

[2019.06.12. 08:30]

»	DGAP-News: Announcement relating to the first tranche of shares to be bought back pursuant to Dialog Semiconductor Plc"s share buyback programme authorised by shareholders at the annual general meeting on 2 May 2019 [2019.06.12. 08:00]

»
DGAP-News: Axel Springer enters into investor agreement with KKR to support long-term growth strategy

[2019.06.12. 07:26]

»	DGAP-News: Axel Springer schließt Investorenvereinbarung mit KKR zur Unterstützung der langfristigen Wachstumsstrategie [2019.06.12. 07:26]

»
DGAP-News: Aus Probiodrug AG wird Vivoryon Therapeutics AG

[2019.06.12. 07:00]
»
DGAP-News: Probiodrug AG becomes Vivoryon Therapeutics AG

[2019.06.12. 07:00]

»	DGAP-News: Nanogate Pushes Ahead With Implementation of the Future-Oriented NXI Program, With One-off Expenses in the Low Single-Digit Million Range [2019.06.11. 14:49]

»	DGAP-News: Nanogate forciert Umsetzung des Zukunftsprogramms NXI - Einmalaufwand im niedrigen einstelligen Millionenbereich [2019.06.11. 14:49]

»	DGAP-News: Xenikos announces IND clearance by the FDA for a pivotal Phase 3 trial using T-Guard(R) for treating steroid-refractory acute GVHD [2019.06.11. 14:00]

»	DGAP-News: Xenikos erhält FDA-Genehmigung zur Durchführung einer pivotalen Phase-3-Studie mit T-Guard(R) zur Behandlung von steroidrefraktärer akuter GVHD [2019.06.11. 14:00]

»
DGAP-News: elumeo SE: elumeo SE veröffentlicht Konzernabschluss für das Jahr 2018

[2019.06.10. 19:43]
»
DGAP-News: elumeo SE: elumeo SE publishes its Consolidated Financial Statements for 2018

[2019.06.10. 19:43]

178/1359

178

Közzétételek - archívum

»	EQS-News: International Cannabis Company Kaya Holdings, Inc. Enters into Strategic Partnership with U.S.-Israeli Cannabis Innovation Lab [2020.07.22. 15:00]

»	EQS-News: International Cannabis Company Kaya Holdings, Inc. and Greek Joint Venture Partner to Launch "Cannamo(TM)" Brand of CBD Pet Products [2020.07.08. 17:15]

»	EQS-News: International Cannabis Company Kaya Holdings, Inc. Files 2019 10-K Detailing Launch of Kaya Brands International and Issuance of Greek Cannabis License, COVID-19 Operational Response Report and 2019 Results of OperationsHoldings, Inc.: [2020.05.20. 20:25]

»	EQS-News: International Cannabis Company Kaya Holdings, Inc. Hails Ontario"s Easing of Cannabis Retail Licensing Restrictions, Readies Plan to Fast Track Kaya Shack(TM) Retail Cannabis Store Franchise Sales [2019.12.17. 14:01]

»	EQS-News: International Cannabis Company Kaya Holdings, Inc. (OTCQB:KAYS) 3rd Quarter 2019 10-Q Details Lower Domestic Costs, Results of 2019 Fall Kaya Farms(TM) Fall Production Run for Hash Oil and Developments in KAYS" Expansion into International Cannabis Markets [2019.11.20. 14:11]

»	DGAP-News: EQS Group AG veröffentlicht Ergebnisse für das 3. Quartal und senkt Prognose für das Geschäftsjahr 2019 [2019.11.14. 19:15]

»	DGAP-News: EQS Group AG publishes third quarter results and lowers forecast for the 2019 financial year [2019.11.14. 19:15]

»	DGAP-Adhoc: EQS Group AG publishes third quarter results and lowers forecast for the 2019 financial year [2019.11.14. 18:50]